Shay Capital’s Achieve Life Sciences ACHV Stock Holding History

Shay Capital’s Portfolio ACHV Stock Details ACHV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$606K	Sell	92,810 -112,304	-55%	-$536K	0.04%	268
2026 Q1	$603K	Sell	205,114 -29,823	-13%	-$132K	0.05%	238
2025 Q4	$1.17M	Sell	234,937 -54,608	-19%	-$238K	0.12%	166
2025 Q3	$912K	Sell	289,545 -3,102	-1%	-$8.51K	0.08%	185
2025 Q2	$661K	Buy	292,647 +26,913	+10%	+$76.7K	0.08%	152
2025 Q1	$710K	Buy	265,734 +240,734	+963%	+$749K	0.1%	114
2024 Q4	$88K	Sell	25,000 -425,000	-94%	-$1.93M	0.01%	281
2024 Q3	$2.13M	Hold	450,000	–	–	0.3%	53
2024 Q2	$2.12M	Hold	450,000	–	–	0.29%	65
2024 Q1	$2.05M	Sell	450,000 -275,000	-38%	-$1.22M	0.32%	55
2023 Q4	$2.99M	Sell	725,000 -16,000	-2%	-$69.7K	0.6%	38
2023 Q3	$3.19M	Sell	741,000 -35,600	-5%	-$179K	0.45%	42
2023 Q2	$4.03M	Buy	776,600 +296,600	+62%	+$2.08M	0.56%	30
2023 Q1	$3.26M	Buy	480,000 +140,000	+41%	+$665K	0.64%	25
2022 Q4	$833K	Hold	340,000	–	–	0.26%	80
2022 Q3	$1.12M	Sell	340,000 -55,759	-14%	-$266K	0.24%	80
2022 Q2	$1.93M	Sell	395,759 -5,609	-1%	-$38K	0.39%	55
2022 Q1	$3.04M	Sell	401,368 -4,349	-1%	-$32.4K	0.39%	32
2021 Q4	$3.16M	Buy	405,717 +25,427	+7%	+$200K	0.52%	35
2021 Q3	$3.23M	Sell	380,290 -22,785	-6%	-$179K	0.42%	51
2021 Q2	$3.62M	Buy	403,075 +268,075	+199%	+$2.55M	0.42%	42
2021 Q1	$1.56M	Buy	+135,000	New	+$1.6M	0.16%	125

Other funds holding ACHV

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Shay Capital's ACHV Position: Q2 2026 in Review

Shay Capital reduced its Achieve Life Sciences (ACHV) stake by 55% in Q2 2026, selling an estimated $536K and leaving 92,810 shares worth $606K. The position accounts for 0.04% of the portfolio, ranked #268.

Shay Capital first reported a position in ACHV in Q1 2021 and has held it in 22 quarters since. The position peaked at $4.03M in Q2 2023. 111 funds tracked by Wall St. Rank hold ACHV as of Q2 2026.

Shay Capital held 92,810 shares of Achieve Life Sciences worth $606K as of Q2 2026.
Shay Capital sold 112,304 Achieve Life Sciences shares in Q2 2026, an estimated $536K.
Achieve Life Sciences made up 0.04% of Shay Capital's portfolio in Q2 2026, its #268 holding.
Shay Capital first reported a position in Achieve Life Sciences in Q1 2021 and has held it in 22 quarters since.
Shay Capital's Achieve Life Sciences position peaked at $4.03M in Q2 2023.
111 funds tracked by Wall St. Rank held Achieve Life Sciences as of Q2 2026.

Based on Shay Capital's 13F filing for Q2 2026, filed 14 Aug 2026.